Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,002,694
-$20,425 QoQ
Shares Held
6,398
-4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#616
of 1,603 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilliland Jeter Wealth Management LLC holds $10,280,824 across 7 Drug Manufacturers - General names. NVS ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,245 | $3,109,862 | |
| 2 | MRK |
Merck & Co., Inc.
|
22,675 | $2,913,737 | |
| 3 | LLY |
ELI LILLY & Co
|
1,603 | $1,922,686 | |
| 4 | NVS |
Novartis AG
This page
|
6,398 | $1,002,694 | |
| 5 | PFE |
Pfizer Inc
|
22,560 | $543,244 | |
| 6 | AMGN |
Amgen Inc
|
1,118 | $404,850 | |
| 7 | ABBV |
AbbVie Inc.
|
1,525 | $383,751 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,002,694 | 6,398 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,023,119 | 6,698 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $931,036 | 6,753 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $866,004 | 6,753 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $832,548 | 6,880 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $778,241 | 6,981 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $644,094 | 6,619 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $23,004 | 200 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $21,292 | 200 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $19,346 | 200 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||